These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16441485)

  • 1. NFkappaB1 gene does not affect type 1 diabetes predisposition in a Spanish population.
    Martínez A; Santiago JL; de la Calle H; Figueredo MA; Fernández-Arquero M; de la Concha EG; Urcelay E
    Tissue Antigens; 2006 Feb; 67(2):143-5. PubMed ID: 16441485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
    Martin J; Perez-Armengol C; Miranda-Filloy JA; Vilchez JR; Lopez-Nevot MA; Garcia-Porrua C; Gonzalez-Gay MA
    J Rheumatol; 2006 Feb; 33(2):285-8. PubMed ID: 16465659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study.
    Santiago JL; Martínez A; de la Calle H; Fernández-Arquero M; Figueredo MA; de la Concha EG; Urcelay E
    BMC Med Genet; 2006 Jun; 7():54. PubMed ID: 16796743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus.
    Orozco G; Sánchez E; Collado MD; López-Nevot MA; Paco L; García A; Jiménez-Alonso J; Martín J
    Tissue Antigens; 2005 Feb; 65(2):183-6. PubMed ID: 15713218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 polymorphisms in Spanish type 1 diabetes patients.
    Urcelay E; Santiago JL; de la Calle H; Martínez A; Figueredo A; Fernández-Arquero M; de la Concha EG
    Genes Immun; 2004 Jun; 5(4):306-9. PubMed ID: 15057267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphism of the NFKB1 gene promoter is not relevant in predisposition to celiac disease.
    Rueda B; Núñez C; López-Nevot MA; Paz Ruiz M; Urcelay E; De la Concha EG; Martín J
    Scand J Gastroenterol; 2006 Apr; 41(4):420-3. PubMed ID: 16635909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intron 4 a/b polymorphism of the endothelial nitric oxide synthase gene is associated with both type 1 and type 2 diabetes in a genetically homogeneous population.
    Galanakis E; Kofteridis D; Stratigi K; Petraki E; Vazgiourakis V; Fragouli E; Mamoulakis D; Boumpas DT; Goulielmos GN
    Hum Immunol; 2008; 69(4-5):279-83. PubMed ID: 18486763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to type 1 diabetes conferred by the PTPN22 C1858T polymorphism in the Spanish population.
    Santiago JL; Martínez A; de la Calle H; Fernández-Arquero M; Figueredo MA; de la Concha EG; Urcelay E
    BMC Med Genet; 2007 Aug; 8():54. PubMed ID: 17697317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXP3 polymorphisms in type 1 diabetes and coeliac disease.
    Bjørnvold M; Amundsen SS; Stene LC; Joner G; Dahl-Jørgensen K; Njølstad PR; Ek J; Ascher H; Gudjònsdòttir AH; Lie BA; Skinningsrud B; Akselsen HE; Rønningen KS; Sollid LM; Undlien DE
    J Autoimmun; 2006 Sep; 27(2):140-4. PubMed ID: 16996248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis.
    Martínez A; Sánchez E; Valdivia A; Orozco G; López-Nevot MA; Pascual-Salcedo D; Balsa A; Fernández-Gutiérrez B; de la Concha EG; García-Sánchez A; Koeleman BP; Urcelay E; Martín J
    Ann Rheum Dis; 2006 Sep; 65(9):1188-91. PubMed ID: 16476711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of MYO9B haplotype with type 1 diabetes.
    Santiago JL; Martínez A; Núñez C; de la Calle H; Fernández-Arquero M; de la Concha EG; Urcelay E
    Hum Immunol; 2008 Feb; 69(2):112-5. PubMed ID: 18361936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association study between CD30 and CD30 ligand genes and type 1 diabetes in the Japanese population.
    Ahmed S; Ihara K; Bassuny WM; Kuromaru R; Kohno H; Miyako K; Matsuura N; Iwata I; Nagafuchi S; Hara T
    Genes Immun; 2002 Apr; 3(2):96-101. PubMed ID: 11960307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
    Zhang D; Ma J; Brismar K; Efendic S; Gu HF
    J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population.
    Bouqbis L; Izaabel H; Akhayat O; Pérez-Lezaun A; Calafell F; Bertranpetit J; Comas D
    Genes Immun; 2003 Mar; 4(2):132-7. PubMed ID: 12618861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.
    Kurylowicz A; Hiromatsu Y; Jurecka-Lubieniecka B; Kula D; Kowalska M; Ichimura M; Koga H; Kaku H; Bar-Andziak E; Nauman J; Jarzab B; Ploski R; Bednarczuk T
    Genes Immun; 2007 Oct; 8(7):532-8. PubMed ID: 17690684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional genetic polymorphisms in cytokines and metabolic genes as additional genetic markers for susceptibility to develop type 1 diabetes.
    Eerligh P; Koeleman BP; Dudbridge F; Jan Bruining G; Roep BO; Giphart MJ
    Genes Immun; 2004 Jan; 5(1):36-40. PubMed ID: 14735147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th1 cytokine polymorphisms in spanish patients with type 1 diabetes.
    Santiago JL; Martínez A; de La Calle H; Fernández-Arquero M; de La Concha EG; Urcelay E
    Hum Immunol; 2005 Aug; 66(8):897-902. PubMed ID: 16216674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor 1 promoter polymorphism influences insulin gene variable number of tandem repeat-associated risk for juvenile onset type 1 diabetes.
    Eerligh P; Roep BO; Giphart MJ; Koeleman BP
    Tissue Antigens; 2004 Jun; 63(6):568-71. PubMed ID: 15140033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT4 polymorphism is associated with early-onset type 1 diabetes, but not with late-onset type 1 diabetes.
    Lee HS; Park H; Yang S; Kim D; Park Y
    Ann N Y Acad Sci; 2008 Dec; 1150():93-8. PubMed ID: 19120275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children.
    Balic I; Angel B; Codner E; Carrasco E; Pérez-Bravo F
    Hum Immunol; 2009 Feb; 70(2):116-20. PubMed ID: 19136037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.